Growth hormone polypeptides and methods of making and using same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9849188
APP PUB NO 20170095567A1
SERIAL NO

14843143

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compositions comprising growth hormone linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of growth hormone-related diseases, disorders, and conditions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AMUNIX PHARMACEUTICALS INC2 TOWER PLACE #1100 SOUTH SAN FRANCISCO CA 94080-1826

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cleland, Jeffrey L San Carlos, US 81 2450
Geething, Nathan Santa Clara, US 29 839
Schellenberger, Volker Palo Alto, US 137 3339
Silverman, Joshua Sunnyvale, US 61 1372
Spink, Benjamin San Carlos, US 39 893
Stemmer, Willem P Los Gatos, US 45 1755
Wang, Chia-wei Milpitas, US 156 2513

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 26, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 26, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00